In the name of GOD 1. Treatment of End Stage Heart Failure Surgical Treatments Cardiac Resynchronization Treatment(CRT) 2.

Slides:



Advertisements
Similar presentations
EP Testing and Use of Devices in Heart Failure HFSA 2010 Recommendations.
Advertisements

Perioperative Management of Heart Failure Gamal Fouad S Zaki, MD Professor of Anesthesiology Ain Shams University
 Heart failure is a complex clinical syndrome Can result from:  structural or functional cardiac disorder  impairs the ability of the ventricle to.
Sur gical Ventricular Remodeling for Congestive Heart Failure
12.4 Guidelines and Format of the Cardiovascular Subsection of CPT The Cardiovascular System subsection: – Heart and Pericardium (33010–33999): Pericardium:
Unit II: Transport Cardiovascular System I
Heart outline pulmonary & systemic circulation
Preliminary results from the C-Pulse OPTIONS HF European Multicenter Post-Market Study Holger Hotz, CardioCentrum Berlin, Berlin, Germany; Antonia Schulz,
Heart Failure: Living with a Hurting Heart. Congestive Heart Failure Heart (or cardiac) failure is the state in which the heart is unable to pump blood.
Between May 2013 and June 2014, we implanted the C-Pulse device in 7 male and 1 female patients with a mean age ± SD of 61.1 ± 9.4 years. Four had ischemic.
Heart Failure Whistle Stop Talks No 1 HFrEF and HFpEF Definitions for Diagnosis Susie Bowell BA Hons, RGN Heart Failure Specialist Nurse.
The Cardiac Cycle. Learning Outcomes During diastole blood returning to the atria flows into the ventricles. Atrial systole transfers the remainder of.
Valvular Heart Disease. Normal heart valves function to maintain the direction of blood flow through the atria and ventricles to the rest of the body.
HEART FAILURE PROF. DR. MUHAMMAD AKBAR CHAUDHRY M.R.C.P.(U.K) F.R.C.P.(E) F.R.C.P.(LONDON) F.A.C.C. DESIGNED AT A.V. DEPTT F.J.M.C. BY RABIA KAZMI.
Diastolic Dysfunction as Diagnosed and Quantified by Echocardiography LAM-1965AO (07/13) For Broker/Dealer Use Only.
Ventricular Assist Devices Brian Schwartz, CCP February 25, 2003.
Common Clinical Scenarios *Younger people *Younger people _Functional murmur vs _Functional murmur vs _ MVP vs _ MVP vs _ AS _ AS *Older people _Aortic.
Heart Failure Ben Starnes MD FACC Interventional Cardiology
U.S. Department of Health and Human Services National Institutes of Health National Heart, Lung, and Blood Institute Quantitative Assessment of Congestive.
Valvular Heart DISEASE
Pharmacotherapy of heart failure 台大藥理所 蘇銘嘉老師. Introduction Heart failure Etiology 1.Hypertension 2.Valvular disease 3.Congenital abnormalities 4.Ischemic.
Treatment of Heart Failure: Beyond Medical Therapy
Current Management of Heart Failure GP clinical update 17 th June 2015 Dr Raj Bilku Consultant Cardiologist Clinical Lead Cardiology QEH.
Indication and contra-indications for cardiac catheterization
Chapter 13 Heart.
The method for evaluating cardiac function by echocardiography
Working Group of Heart Failure and Cardiac Function How to evaluate and treat dyssynchrony ? P Lancellotti, LA Piérard, Liège, BE.
Blood Pressure. Blood pressure is the force exerted by the blood against the walls of the blood vessels. It is necessary to maintain blood flow though.
Medical Progress: Heart Failure. Primary Targets of Treatment in Heart Failure. Treatment options for patients with heart failure affect the pathophysiological.
Target Study Cardiac resynchronization therapy (CRT) is an established treatment for advanced heart failure symptoms, impaired LV systolic function, and.
Cardio Investigations. Patients presenting with chest pain may be identified as having definite or possible angina from their history alone. Risk Factor.
Abnormalities of the Conduction System Elizabeth Dugan - Olamide Odubogun -
Human Anatomy, 3rd edition Prentice Hall, © 2001 The Heart Chapter 21.
Angina & Dysrhythmias. A & P OF THE CARDIAC SYSTEM Cardiac output  CO=SV(stroke volume) X HR(heart rate) Preload  Volume of blood in the ventricles.
Frank-Starling Mechanism
The Heart Unit 11. The heart is the pump that keeps blood moving around a closed circuit of blood vessels. It beats over 100,000 times a day. Introduction.
Anatomy & Physiology/Cardiovascular System. About the size of a an adult fist Hollow and cone shaped Weighs less than a pound Sits atop the diaphragm.
The Cardiovascular System and Its Control. The Cardiovascular System: Major Functions Delivers O 2, nutrients Removes CO 2, other waste Transports hormones,
Circulation and the heart Topical outline. I-Location of the heart I-Location of the heart II-Structure of the heart II-Structure of the heart Division.
Chapter 9 Heart. Review of Structure and Function The heart is divided into the systemic (left) and pulmonary (right) systems –The pulmonary system has.
Ch 20 – The Heart.
Intra-Aortic Balloon Pump What it is and what it does
Dr Eric Prystowsky Director Clinical Electrophysiology Laboratory St Vincent Hospital, Indianapolis Dr Leslie Saxon Chief, Electrophysiology Laboratory.
© 2009 Delmar, Cengage Learning Chapter 13 Heart.
The Heart. Pulmonary Circulation and Systemic Circulation The heart is considered to be a double pump because it pumps blood through 2 different loops:
Terapie chirurgiche dell’Insufficienza Cardiaca
The Cardiac Cycle. Systole – contraction Diastole – relaxation PLEASE SEE THE HANDOUT ON THE WIKI FOR DETAILS OF EACH STEP.
Heart. The Cardiovascular System The heart beats about 100,000 times/day, 35 million times/year In a resting adult the heart rate is about 75 beats/minute.
Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients with Heart Failure with preserved Ejection Fraction Effect of Spironolactone.
Heart Structure and Function The gross structure of the human heart and its associated blood vessels in relation to function. Heart Structure, Cardiac.
Patient Selection & Risk Stratification Soltani GH, MD.
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Atrial Septal Defect R3 이재연.
Left Ventricular Filling Pressure by Doppler Echocardiography in Patients With End-Stage Renal Disease Angela Y-M Wang, Mei Wang, Christopher W-K Lam,
AICE Biology, Chapter 9 The Mammalian Heart. The Heart Location – Thorax between the lungs in the inferior mediastinum Orientation – Pointed apex directed.
CRT Overview This lecture is intended to give a basic overview of HF to include: -General knowledge of the cardiac cycle and how a normal heart should.
Ventricular resection in cardiac failure
Management of mitral regurgitation. See legend for Fig
Cardiothoracic Surgery
The Mammalian Circulatory System
Dr M B Connellan Stellenbosch University
The method for evaluating cardiac function by echocardiography
The Heart.
Mechanical Circulatory Support Devices HOSEIN PASANDI.
Zoll Firm Lecture Series
The Blood System.
The Circulatory System
Khalid AlHabib Professor of Cardiac Sciences Cardiology Consultant
Rick A. Nishimura et al. JACC 2017;70:
Introduction; The Cardiovascular System (CVS)
Presentation transcript:

In the name of GOD 1

Treatment of End Stage Heart Failure Surgical Treatments Cardiac Resynchronization Treatment(CRT) 2

Surgical Treatment of Heart Failure CABGs in ischemic cardiomyopathy Mitral valve repair in patients with dilated cardiomyopathy Surgical Ventricular reconstruction(Dor procedure) Passive Cardiac support Device Heart Transplantation 3

Dor procedure for Ischemic Cardiomyopathy Purse string stitch around a nonviable scarred aneurysm to minimize the excluded area. The residual defect is sometimes covered by a patch made from Dacron, pericardium, or an autologous tissue flap 4

Dor procedure for Ischemic Cardiomyopathy The operation shortens the long axis, but leaves the short axis length unchanged, producing an increase in ventricular diastolic sphericity while the systolic shape becomes more elliptical 5

Cardiomyoplasty Cardiomyoplasty, also referred to as "dynamic cardiomyoplasty," Surgical therapy for dilated cardiomyopathy in which the latissimus dorsi muscle is wrapped around the heart and paced during ventricular systole. 6

Carpentier peformed the first successful surgery on a humen in 1985 Cardiomyoplasty 7

Considered Criteria for Surgical Repair Anteroseptal MI, with dilated left ventricle (end-diastolic volume index >100 mL/m2) Depressed LVEF Left ventricular regional dyskinesis or akinesis >30 percent of the ventricular perimeter, and Either symptoms of angina, heart failure, or arrhythmias 8

The following are considered to be relative contraindications Systolic pulmonary artery pressure >60 mmHg Severe right ventricular dysfunction Regional dyskinesis or akinesis without dilation of the ventricle 9

LV Reconstruction for Non- ischemic Cardiomyopathy Cardiomyoplasty experience has led to other novel approaches to heart failure. Observations suggested that some patients benefited from the diastolic "girdling" effect of the muscle wrap This observation led to the development of the Acorn device and Myosplint 10

LV Reconstruction for Non- ischemic Cardiomyopathy Acorn device knitted polyester sock that is drawn up and anchored over the ventricles in order to limit left ventricular dilation Preliminary data suggest that the device produces an improvement in heart failure symptoms, LVEF, left ventricular end- diastolic dimension, and quality of life 11

INTRODUCTION Heart transplantation remains the ultimate treatment for heart failure 12

HEART TRANSPLANTATION ACTUARIAL SURVIVAL ( ) N=52,195 Half-life =9.1 years Conditional Half-life = 11.6 years 13

Who Should Not Be Offered a Heart Transplant? Irreversible PHTN or pulmonary parenchymal disease Irreversible renal or hepatic dysfunction Severe peripheral or cerebrovascular disease IDDM with end-organ damage Coexisting cancer Non-compliance, addiction Elderly patients (aprox > 70yo) 14

Intraaortic Balloon Pump (IABP) Provides temporary circulatory assistance –↓ Afterload –Augments aortic diastolic pressure Outcomes –Improved coronary blood flow –Improved perfusion of vital organs 15

Ventricular Assist Devices (VADs) 16

Left ventricular assist device 17

Cardiac Resynchronization Therapy for Heart Failure Patient Selection and Clinical Outcomes 18

CRT-Cardiac Resynchronization CRT-Cardiac Resynchronization Therapy CRT-Cardiac Resynchronization HOW IT WORKS: Standard implanted pacemakers - equipped with two wires (or "leads") conduct pacing signals to specific regions of heart (usually at positions A and C). Biventricular pacing devices have added a third lead (to position B) that is designed to conduct signals directly into the left ventricle. Combination of all three lead > synchronized pumping of ventricles, inc. efficiency of each beat and pumping more blood on the whole. 19

Ventricular Dysynchrony Abnormal ventricular conduction resulting in a mechanical delay –Wide QRS (IVCD); typically LBBB morphology –Poor systolic function –Impaired diastolic function ECG depicting interventricular conduction delay 20

Cardiac Resynchronization Therapy Goals Improve hemodynamics Improve Quality of Life 21

Cardiac Resynchronization Therapy Cardiac resynchronization, in association with an optimized AV delay, improves hemodynamic performance by forcing the left ventricle to complete contraction and begin relaxation earlier, allowing an increase in ventricular filling time. Coordinate activation of the ventricles and septum. ECG depicting cardiac resynchronization ECG depicting IVCD 22

Transvenous Approach –Standard pacing leads in RA and RV –Specially designed left heart lead placed in a left ventricular cardiac vein via the coronary sinus Achieving Cardiac Resynchronization Mechanical Goal: Pace Right and Left Ventricles Cardiac Resynchronization System

MIRACLE Study Population Symptomatic patients with heart failure  18 years of age NYHA Functional Class III or IV QRS duration  130 msec LVEF  35% by echocardiography LVEDD  55 millimeters (echo measure) Stable HF medical regimen for  1-month –ACE-I or substitute, if tolerated –β-blocker - stable regimen for  3-months Abraham WT, et al. Journal of Cardiac Failure 2000; Vol 6 No

THANKS FOR YOUR ATTENTION 25